Page last updated: 2024-09-03

gefitinib and alamethicin

gefitinib has been researched along with alamethicin in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (alamethicin)	Trials (alamethicin)	Recent Studies (post-2010) (alamethicin)
5,231	566	2,919	619	0	113

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
An, K; Ishii, Y; Nishimura, Y; Yamada, H	1

Other Studies

1 other study(ies) available for gefitinib and alamethicin

Article	Year
ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:11 Topics: Adenine; Adenosine Monophosphate; Adenosine Triphosphate; Alamethicin; Animals; Catalytic Domain; Cetomacrogol; Endoplasmic Reticulum; Gefitinib; Glucuronosyltransferase; Humans; Male; Microsomes, Liver; NADP; Quinazolines; Rats; Rats, Sprague-Dawley; UDP-Glucuronosyltransferase 1A9	2012

Article

Year

ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:11

Topics: Adenine; Adenosine Monophosphate; Adenosine Triphosphate; Alamethicin; Animals; Catalytic Domain; Cetomacrogol; Endoplasmic Reticulum; Gefitinib; Glucuronosyltransferase; Humans; Male; Microsomes, Liver; NADP; Quinazolines; Rats; Rats, Sprague-Dawley; UDP-Glucuronosyltransferase 1A9

2012